New injection heals heart after attack, may prevent failure before it begins

Researchers from UC San Diego and Northwestern University have developed an innovative intravenous therapy for heart attack victims. The treatment uses a protein-like polymer to target inflammation at the molecular level, promoting healing and reducing heart failure risk. Animal trials showed significant improvements in cardiac function and tissue repair weeks after a heart attack. This approach could potentially be applied to other diseases, offering a new strategy for addressing intracellular protein interactions in various health conditions.